Jonathan Aschoff
Stock Analyst at Roth MKM
(0.02)
# 4,333
Out of 4,334 analysts
432
Total ratings
30.2%
Success rate
-19.2%
Average return
Main Sectors:
Stocks Rated by Jonathan Aschoff
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GOVX GeoVax Labs | Maintained: Buy | $10 | $3.64 | +174.73% | 14 | May 15, 2026 | |
| BFRI Biofrontera | Maintained: Buy | $9 | $0.8073 | +1,014.83% | 12 | May 15, 2026 | |
| PTHS Pelthos Therapeutics | Maintained: Buy | $55 | $26.66 | +106.30% | 5 | May 15, 2026 | |
| APVO Aptevo Therapeutics | Maintained: Buy | $21 | $4.95 | +324.24% | 10 | May 14, 2026 | |
| CLNN Clene | Maintained: Buy | $30 | $6.70 | +347.76% | 6 | May 14, 2026 | |
| REVB Revelation Biosciences | Maintained: Buy | $16 | $1.07 | +1,395.33% | 13 | May 8, 2026 | |
| MDCX Medicus Pharma | Maintained: Buy | $9 | $0.30 | +2,900.00% | 2 | May 7, 2026 | |
| CLRB Cellectar Biosciences | Rated: Buy | $14 → $11 | $3.20 | +243.75% | 10 | May 5, 2026 | |
| CELZ Creative Medical Technology Holdings | Maintained: Buy | $20 | $2.39 | +736.82% | 7 | Apr 28, 2026 | |
| BRTX BioRestorative Therapies | Maintained: Buy | $18 → $15 | $0.208 | +7,111.54% | 10 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $3 | $0.44 | +581.82% | 5 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 | $2.39 | +1,197.07% | 16 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $10.03 | +109.37% | 15 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $3 | $0.0001 | +2,999,900.00% | 8 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $2 | $0.04 | +4,900.00% | 11 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $12.13 | n/a | 7 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $11 | $1.05 | n/a | 5 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $3.09 | n/a | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $10.35 | n/a | 1 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.97 | n/a | 5 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.42 | $0.11 | n/a | 1 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $36 | $4.84 | n/a | 9 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $36 | $22.50 | n/a | 2 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $250 → $24 | $2.29 | n/a | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $620 → $500 | $0.001 | n/a | 3 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $8.78 | n/a | 2 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $1.34 | n/a | 1 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $30 | $0.1831 | n/a | 3 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $0.3795 | n/a | 5 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $2.5 → $8 | $0.0001 | n/a | 5 | Sep 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $0.000001 | n/a | 4 | Aug 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $38 | $9.91 | n/a | 1 | Mar 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $0.00165 | n/a | 3 | Nov 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $8 | $1.35 | n/a | 17 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $11 | $3.62 | n/a | 3 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $26 | $1.45 | n/a | 2 | Jul 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.8095 | n/a | 1 | Apr 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $0.011 | n/a | 8 | Sep 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.95 | n/a | 12 | Sep 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $0.8588 | n/a | 17 | Sep 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $235.97 | n/a | 5 | Aug 19, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $92 | $97.16 | n/a | 14 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $0.4608 | n/a | 10 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $16 | $30.73 | n/a | 11 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $4 → $3 | $0.7931 | n/a | 12 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $38.87 | n/a | 21 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $1.02 | n/a | 12 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $0.7313 | n/a | 6 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $23.35 | n/a | 16 | Aug 5, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $18 | $66.61 | n/a | 13 | Aug 4, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.000001 | n/a | 10 | Jul 6, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $489 | $638.88 | n/a | 18 | Mar 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.3901 | n/a | 4 | Nov 12, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $1.07 | n/a | 3 | Dec 8, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $54.09 | n/a | 3 | Oct 24, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $568.43 | n/a | 1 | Feb 26, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1 | $2.20 | n/a | 1 | Jan 17, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $28.34 | n/a | 2 | Jun 29, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $11 | $68.32 | n/a | 2 | Apr 16, 2012 |
GeoVax Labs
May 15, 2026
Maintained: Buy
Price Target: $10
Current: $3.64
Upside: +174.73%
Biofrontera
May 15, 2026
Maintained: Buy
Price Target: $9
Current: $0.8073
Upside: +1,014.83%
Pelthos Therapeutics
May 15, 2026
Maintained: Buy
Price Target: $55
Current: $26.66
Upside: +106.30%
Aptevo Therapeutics
May 14, 2026
Maintained: Buy
Price Target: $21
Current: $4.95
Upside: +324.24%
Clene
May 14, 2026
Maintained: Buy
Price Target: $30
Current: $6.70
Upside: +347.76%
Revelation Biosciences
May 8, 2026
Maintained: Buy
Price Target: $16
Current: $1.07
Upside: +1,395.33%
Medicus Pharma
May 7, 2026
Maintained: Buy
Price Target: $9
Current: $0.30
Upside: +2,900.00%
Cellectar Biosciences
May 5, 2026
Rated: Buy
Price Target: $14 → $11
Current: $3.20
Upside: +243.75%
Creative Medical Technology Holdings
Apr 28, 2026
Maintained: Buy
Price Target: $20
Current: $2.39
Upside: +736.82%
BioRestorative Therapies
Apr 2, 2026
Maintained: Buy
Price Target: $18 → $15
Current: $0.208
Upside: +7,111.54%
Mar 2, 2026
Maintained: Buy
Price Target: $8 → $3
Current: $0.44
Upside: +581.82%
Feb 23, 2026
Maintained: Buy
Price Target: $31
Current: $2.39
Upside: +1,197.07%
Jul 22, 2025
Maintained: Buy
Price Target: $21
Current: $10.03
Upside: +109.37%
Jul 8, 2025
Maintained: Buy
Price Target: $4 → $3
Current: $0.0001
Upside: +2,999,900.00%
Jun 4, 2025
Maintained: Buy
Price Target: $9 → $2
Current: $0.04
Upside: +4,900.00%
May 15, 2025
Maintained: Buy
Price Target: $30
Current: $12.13
Upside: n/a
May 13, 2025
Maintained: Buy
Price Target: $13 → $11
Current: $1.05
Upside: n/a
May 12, 2025
Maintained: Buy
Price Target: $12
Current: $3.09
Upside: n/a
Oct 28, 2024
Maintained: Buy
Price Target: $20
Current: $10.35
Upside: n/a
Oct 23, 2024
Downgraded: Hold
Price Target: n/a
Current: $0.97
Upside: n/a
Sep 3, 2024
Maintained: Buy
Price Target: $0.42
Current: $0.11
Upside: n/a
May 21, 2024
Rated: Buy
Price Target: $36
Current: $4.84
Upside: n/a
Mar 7, 2024
Maintained: Buy
Price Target: $25 → $36
Current: $22.50
Upside: n/a
Mar 5, 2024
Maintained: Buy
Price Target: $250 → $24
Current: $2.29
Upside: n/a
Dec 18, 2023
Maintained: Buy
Price Target: $620 → $500
Current: $0.001
Upside: n/a
Feb 27, 2023
Maintained: Buy
Price Target: $14
Current: $8.78
Upside: n/a
Jun 15, 2022
Initiated Coverage: Buy
Price Target: $8
Current: $1.34
Upside: n/a
Apr 28, 2022
Maintained: Buy
Price Target: $4 → $30
Current: $0.1831
Upside: n/a
Oct 25, 2021
Reiterated: Buy
Price Target: $24
Current: $0.3795
Upside: n/a
Sep 27, 2021
Upgraded: Buy
Price Target: $2.5 → $8
Current: $0.0001
Upside: n/a
Aug 30, 2021
Maintained: Buy
Price Target: $7
Current: $0.000001
Upside: n/a
Mar 11, 2021
Initiated Coverage: Buy
Price Target: $38
Current: $9.91
Upside: n/a
Nov 22, 2020
Maintained: Buy
Price Target: $18
Current: $0.00165
Upside: n/a
Nov 17, 2020
Downgraded: Sell
Price Target: $8
Current: $1.35
Upside: n/a
Oct 14, 2020
Reiterated: Buy
Price Target: $14 → $11
Current: $3.62
Upside: n/a
Jul 14, 2020
Maintained: Buy
Price Target: $13 → $26
Current: $1.45
Upside: n/a
Apr 20, 2020
Reiterated: Buy
Price Target: $9
Current: $0.8095
Upside: n/a
Sep 15, 2016
Reiterated: Buy
Price Target: $14
Current: $0.011
Upside: n/a
Sep 13, 2016
Reiterated: Buy
Price Target: $4
Current: $1.95
Upside: n/a
Sep 9, 2016
Reiterated: Buy
Price Target: $55
Current: $0.8588
Upside: n/a
Aug 19, 2016
Reiterated: Buy
Price Target: $29
Current: $235.97
Upside: n/a
Aug 10, 2016
Reiterated: Buy
Price Target: $92
Current: $97.16
Upside: n/a
Aug 10, 2016
Reiterated: Buy
Price Target: $24
Current: $0.4608
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $24 → $16
Current: $30.73
Upside: n/a
Aug 9, 2016
Reiterated: Sell
Price Target: $4 → $3
Current: $0.7931
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $28
Current: $38.87
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $26
Current: $1.02
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $16
Current: $0.7313
Upside: n/a
Aug 5, 2016
Reiterated: Hold
Price Target: n/a
Current: $23.35
Upside: n/a
Aug 4, 2016
Reiterated: Buy
Price Target: $16 → $18
Current: $66.61
Upside: n/a
Jul 6, 2016
Reiterated: Buy
Price Target: $8
Current: $0.000001
Upside: n/a
Mar 8, 2016
Initiated Coverage: Buy
Price Target: $489
Current: $638.88
Upside: n/a
Nov 12, 2015
Reiterated: Buy
Price Target: $5
Current: $0.3901
Upside: n/a
Dec 8, 2014
Maintained: Buy
Price Target: $16
Current: $1.07
Upside: n/a
Oct 24, 2014
Maintained: Hold
Price Target: n/a
Current: $54.09
Upside: n/a
Feb 26, 2013
Downgraded: Hold
Price Target: n/a
Current: $568.43
Upside: n/a
Jan 17, 2013
Downgraded: Sell
Price Target: $1
Current: $2.20
Upside: n/a
Jun 29, 2012
Reiterated: Buy
Price Target: n/a
Current: $28.34
Upside: n/a
Apr 16, 2012
Maintained: Buy
Price Target: $13 → $11
Current: $68.32
Upside: n/a